CETP inhibitors

Alzheimers research brain scientist magnifying glass questions neuro

NewAmsterdam links lipid drug to drop in Alzheimer's biomarker

The phase 3 sub-study tracked significant changes in an biomarker, adding to evidence that CETP inhibition may cut the risk of developing Alzheimer’s.

Nick Paul Taylor Jun 9, 2025 8:25am

NewAmsterdam shares more data on lipid-lowering Amgen castoff

Apr 9, 2024 5:30am

NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2

Jan 17, 2023 9:15am

NewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug

Jan 14, 2021 8:35am

Esperion tees up to launch cholesterol-busting meds—affordably

Jan 14, 2020 8:30am

ACC: Merck anacetrapib reveal bodes neutral at best for DalCor

Mar 20, 2019 10:19am